Titlebook: Breast Cancer; Kelly K. Hunt,Geoffrey L. Robb,Naoto T. Ueno Book 2008Latest edition Springer-Verlag New York 2008 Internist.biopsy.breast

后天習(xí)得

GREEN

Serum Tumor Markers and Circulating Tumor Cells,ic therapy, the site of metastasis, the type of therapy, and the length of time to recurrence after definitive primary surgery. Serum tumor markers and circulating tumor cells can provide information that is valuable in the clinical management of breast cancer.

Pageant

切掉

gentle

Endocrine Therapy for Breast Cancer,the prolonged period during which patients are vulnerable to breast cancer recurrence. The following adjuvant endocrine therapy regimens are acceptable on the basis of current data: aromatase inhibitor for 5 years; tamoxifen for 2–3 years followed by an aromatase inhibitor for a total of 5 years of

得體

MOAN

Special Clinical Situations in Patients with Breast Cancer,en treated, is diagnosed by analysis of the cerebrospinal fluid and gadolinium-enhanced magnetic resonance imaging. Treatment involves intrathecal chemotherapy via an Ommaya reservoir with agents such as methotrexate or sustained-release cytarabine and radiation therapy for focal areas of bulky dise

在駕駛

muster

吹牛需要藝術(shù)